Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K991125
    Date Cleared
    1999-09-14

    (165 days)

    Product Code
    Regulation Number
    886.5928
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SAUFLON AEROTAB DISINFECTING SYSTEM is indicated for chemical disinfection and storage of clear (untinted) soft (hydrophilic) contact lenses.

    The AEROSOLV UNPRESERVED BUFFERED SALINE SOLUTION is indicated for the rinsing of soft contact lenses after cleaning, dissolving of the Sauflon AEROTAB Disinfecting Tablet to make the disinfecting/ storage solution, and rinsing of the soft contact lenses prior to insertion onto the eye.

    The SAUFLON Barrel Lens Case is to be used with the AEROSOLV UNPRESERVED BUFFERED SALINE SOLUTION and Sauflon AEROTAB Disinfecting Tablets as the lens case for chemical disinfection and storage of clear (untinted) soft (hydrophilic) contact lenses .

    The SAUFLON barrel lens case may also be used as the lens case for storage of soft (hydrophilic) contact lenses during chemical disinfection only. DO NOT USE WITH HEAT OR HYDROGEN PEROXIDE SYSTEMS.

    Device Description

    The Sauflon Aerotab Disinfecting Tablet contains halazone (4-carboxyphenyl N-chloro sulphonamide) as the active ingredient, with an effervescent base of adipic acid and anhydrous sodium carbonate. There is no preservative in the tablet. AEROSOLV Unpreserved Buffered Saline Solution is a sterile, aqueous, isotonic solution of sodium chloride buffered with boric acid and sodium borate.

    The Sauflon AEROTAB disinfecting system was shown to be compatible with clear (untinted) soft (hydrophilic) contact lenses .

    AI/ML Overview

    The Sauflon AEROTAB Disinfecting System (composed of the Sauflon AEROTAB Disinfecting Tablet, AEROSOLV Unpreserved Buffered Saline Solution, and Sauflon Barrel Lens Case) was evaluated through several studies to meet its acceptance criteria for chemical disinfection and storage of soft (hydrophilic) contact lenses.

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategorySpecific CriteriaReported Device PerformanceStudy Type
    MicrobiologyMeets Stand-Alone Procedure for Disinfecting Products requirementsEfficacy maintained throughout labeled shelf-lifeMicrobiology
    Clinical Safety (Adverse Reactions)No adverse reactionsNo adverse reactions observedClinical Trial
    Clinical Safety (Ocular Findings)Acceptable percentage of "no positive slit lamp findings"90% of eye examinations showed no positive slit lamp findings (compared to 67% for peroxide control)Clinical Trial
    Clinical Safety (Symptoms)Acceptable percentage of "no symptoms reported"81% of visits reported no symptoms (compared to 85% for peroxide control, considered not significantly different)Clinical Trial
    Clinical Efficacy (Visual Acuity)Appropriate visual acuity (within 2 Snellen lines of original best corrected acuity)95% of test eyes achieved appropriate visual acuityClinical Trial
    Clinical Efficacy (Lens Cleanliness)Acceptable percentage of "clinically clean" lenses93% of test lenses were clinically clean at scheduled visitsClinical Trial
    Toxicology (Cytotoxicity)No cytotoxicityNo cytotoxicity reported for lenses disinfected for 30 cyclesToxicology
    Toxicology (Ocular Irritation)No ocular irritationNo ocular irritation reported for lenses disinfected for 30 cyclesToxicology
    Toxicity (Lens Case Components)Compliance with USP XXIII for Plastics for Ophthalmic ProductsComponents passed USP XXIII requirementsToxicology
    Lenses CompatibilityCompatibility with clear (untinted) soft (hydrophilic) contact lensesShown to be compatibleProduct Description

    2. Sample Size Used for the Test Set and Data Provenance

    • Clinical Trial: 334 subjects (276 test, 58 control). The provenance of the data (country of origin, retrospective/prospective) is not explicitly stated in the provided text. However, the study involved a "6 month clinical trial," which typically implies a prospective design.
    • Toxicology: Hydrophilic lenses representative of all four groups were disinfected for 30 cycles. The exact number of lenses is not specified.
    • Microbiology: Not specified, but the "Stand-Alone Procedure for Disinfecting Products" would involve specific laboratory testing.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts

    The provided text does not specify the number or qualifications of experts used to establish the ground truth for the test set. For the clinical trial, "no positive slit lamp findings" and "clinically clean" lenses likely involved evaluations by ophthalmologists or optometrists, but their specific qualifications or number are not detailed.

    4. Adjudication Method for the Test Set

    The document does not describe the adjudication method used for the test set.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size

    No MRMC comparative effectiveness study involving human readers with and without AI assistance was mentioned. The clinical trial compared the Sauflon AEROTAB Disinfecting Tablet system to a "commercial peroxide disinfecting system," which is a comparison of two different disinfecting methods, not an AI assistance study.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This device is a chemical disinfecting system, not an AI algorithm. Therefore, the concept of an "algorithm only without human-in-the-loop performance" does not apply. The clinical and microbiological studies represent the "standalone" performance of the disinfecting system itself.

    7. The Type of Ground Truth Used

    • Clinical Trial: The ground truth for the clinical trial would be a combination of:
      • Expert Clinical Assessment: Slit lamp findings, visual acuity measurements (likely by trained professionals), and assessment of lens cleanliness.
      • Patient-Reported Outcomes: Symptoms reported by subjects.
    • Toxicology: Expert assessment of cytotoxicity and ocular irritation (e.g., cell viability assays, animal models or in-vitro tests for ocular irritation).
    • Microbiology: Laboratory testing according to the "Stand-Alone Procedure for Disinfecting Products," which would have defined metrics for microbial kill.

    8. The Sample Size for the Training Set

    The concept of a "training set" is not applicable as this is a physical medical device (disinfecting system), not a machine learning algorithm.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, as there is no training set for this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1